August 2011 Dialogues in Dermatology Issue
Includes 3 Interviews:
Cancer Therapy Eruptions (Part 2): Chemotherapy and Kinase Inhibitors
Milan Anadkat, MD interviewed by Michael Heffernan
Variants of Cutaneous T Cell Lymphoma
by Jacqueline Junkins-Hopkins, MD
interviewed by Warren Heymann, MD
Pediatric Procedure Compliance Tips
by Kenneth Bloom, MD interviewed by
Gary Brauner, MD
Target Audience: Dermatologists and other health care
professionals who wish to access and update their current knowledge of
Learning Objectives: At the conclusion of this learning
activity, participants should be able to:
1. Identify cutaneous reactions that
may result from kinase inhibitors.
2. Recognize the spectrum of clinical and
histologic variants of mycosis fungoides/cutaneous T cell lymphoma.
Describe strategies to help pediatric patients avoid extreme anxiety levels when
encountering office-based procedures.
CME credit is only available to purchasers. CME expires August 31,
The American Academy of
Dermatology is accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
American Academy of Dermatology designates this enduring material for a maximum
of 2.00 AMA PRA Category 1 Credits™.
Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
AAD Recognized Credit Statement
Dialogues in Dermatology
is recognized by the American Academy of Dermatology for 2.00 AAD Recognized
Credit and may be used toward the AAD Continuing Medical Education Award.
Supported browsers: FireFox (3+),
Google Chrome (5+), Internet Explorer (7+), Safari (5+), Opera (10+).
Adobe Reader (or other PDF reader) to
view PDF files.